In the present study, we show that pemetrexed, but not the other commonly used chemotherapeutics (eg, cisplatin and PTX), is capable of inducing PD-L1 expression in NSCLC cells that further primes the tumor microenvironment favorable to the ICB therapy. Here, CD274 is linked to neoplasm.